Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease

American Journal of Pathology

Volumn 172, Issue 2, 2008, Pages 430-439

  Suva, Larry J ^a   Hartman, Eric ^a   Dilley, Joshua D ^a   Russell, Susan ^a   Akel, Nisreen S ^a   Skinner, Robert A ^a   Hogue, William R ^a   Budde, Ulrich ^b   Varughese, Kottayil I ^a   Kanaji, Taisuke ^c   Ware, Jerry ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Labor Prof Arndt and Partner   (Germany)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN IB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING TIME; BONE MARROW CULTURE; BONE MASS; CELL DIFFERENTIATION; CONTROLLED STUDY; CORTICAL BONE; FEMUR; FLOW CYTOMETRY; GENE EXPRESSION; HEMATOPOIETIC CELL; LYMPHOCYTE TRANSFORMATION; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; SPLENOMEGALY; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION; TIBIA; TRABECULAR BONE; VON WILLEBRAND DISEASE;

EID: 39549109062     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.070417     Document Type: Article

References (56)

1. Ware J: Dysfunctional platelet membrane receptors: from humans to mice. Thromb Haemost 2004, 92:478-485
2. Miller JL, Castella A: Platelet-type von Willebrand's disease: characterization of a new bleeding disorder. Blood 1982, 60:790-794
3. Miller JL, Kupinski JM, Castella A, Ruggeri ZM: von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease. J Clin Invest 1983, 72:1532-1542
4. Nichols WC, Cooney KA, Ginsburg D, Ruggeri ZM: von Willebrand disease. Thrombosis and Hemorrhage. Edited by Loscalzo J, Schafer AI. Baltimore, Williams & Wilkins 1998, pp 729-756
5. Sadler JE: Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998, 67:395-424
6. Miller JL, Cunningham D, Lyle VA, Finch CL: Mutation in the gene encoding the α chain of platelet glycoprotein Ib in platelet-type von Willebrand disease. Proc Natl Acad Sci USA 1991, 88:4761-4765
7. Murata M, Russell SR, Ruggeri ZM, Ware J: Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ibα fragment. J Clin Invest 1993, 91:2133-2137
8. Moriki T, Murata M, Kitaguchi T, Anbo H, Handa M, Watanabe K, Takahashi H, Ikeda Y: Expression and functional characterization of an abnormal platelet membrane glycoprotein Ib alpha (Met239->Val) reported in patients with platelet-type von Willebrand disease. Blood 1997, 90:698-705
9. López JA, Leung B, Reynolds CC, Li CQ, Fox JEB: Efficient plasma membrane expression of a functional platelet glycoprotein Ib-IX complex requires the presence of its three subunits. J Biol Chem 1992, 267:12851-12859
10. Andrews RK, Gardiner EE, Shen Y, Whisstock JC, Berndt MC: Glycoprotein Ib-IX-V. Int J Biochem Cell Biol 2003, 35:1170-1174
11. Takahashi H, Murata M, Furukawa T, Handa M, Watanabe K, Ikeda Y: A point mutation in gene encoding glycoprotein IBα in a Japanese family with platelet-type von Willebrand disease. Blood 1992, 80:130a
12. Matsubara Y, Murata M, Sugita K, Ikeda Y: Identification of a novel point mutation in platelet glycoprotein Ibα. Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease. J Thromb Haemost 2003, 1:2198-2205
13. Othman M, Notley C, Lavender FL, White H, Byrne CD, Lillicrap D, O'Shaughnessy DF: Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease. Blood 2005, 105:4330-4336
14. Huizinga EG, Tsuji S, Romijn RA, Schiphorst ME, de Groot PG, Sixma JJ, Gros P: Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain. Science 2002, 297:1176-1179
15. Ware J, Russell S, Ruggeri ZM: Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Proc Natl Acad Sci USA 2000, 97:2803-2808
16. Kacena MA, Gundberg CM, Nelson T, Horowitz MC: Loss of the transcription factor p45 NF-E2 results in a developmental arrest of megakaryocyte differentiation and the onset of a high bone mass phenotype. Bone 2005, 36:215-223
17. Beeton CA, Bord S, Ireland D, Compston JE: Osteoclast formation and bone resorption are inhibited by megakaryocytes. Bone 2006, 39:985-990
18. Kacena MA, Nelson T, Clough ME, Lee SK, Lorenzo JA, Gundberg CM, Horowitz MC: Megakaryocyte-mediated inhibition of osteoclast development. Bone 2006, 39:991-999
19. Ware J, Russell SR, Marchese P, Ruggeri ZM: Expression of human platelet glycoprotein Ibα in transgenic mice. J Biol Chem 1993, 268:8376-8382
20. Fujita H, Hashimoto Y, Russell S, Zieger B, Ware J: In vivo expression of murine platelet glycoprotein Ibα. Blood 1998, 92:488-495
21. Budde U, Schneppenheim R, Plendle H, Dent J, Ruggeri ZM, Zimmerman TS: Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes. Thromb Haemost 1990, 63:312-315
22. Rzonca SO, Suva LJ, Gaddy D, Montague DC, Lecka-Czernik B: Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 2004, 145:401-406
23. Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P: Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 1999, 14:1167-1174
24. Bagi CM, Hanson N, Andresen C, Pero R, Lariviere R, Turner CH, Laib A: The use of micro-CT to evaluate cortical bone geometry and strength in nude rats: correlation with mechanical testing, pQCT and DXA. Bone 2006, 38:136-144
25. Skinner R, Hickmon S, Lumpkin CJ, Aronson J, Nicholas R: Twenty years of successful specimen management. J Histotechnol 1997, 20:267-277
26. Bendre MS, Gaddy-Kurten D, Mon-Foote T, Akel NS, Skinner RA, Nicholas RW, Suva LJ: Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res 2002, 62:5571-5579
27. Suva LJ, Seedor JG, Endo N, Quartuccio HA, Thompson DD, Bab I, Rodan GA: Pattern of gene expression following rat tibial marrow ablation. J Bone Miner Res 1993, 8:379-388
28. Perrien DS, Akel NS, Dupont-Versteegden EE, Skinner RA, Siegel ER, Suva LJ, Gaddy D: Aging alters the skeletal response to disuse in the rat. Am J Physiol 2007, 292:R988-R996
29. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR: Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610
30. Gaddy-Kurten D, Coker JK, Abe E, Jilka RL, Manolagas SC: Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures. Endocrinology 2002, 143:74-83
31. Lazarenko OP, Rzonca SO, Hogue WR, Swain FL, Suva LJ, Lecka-Czernik B: Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone. Endocrinology 2007, 148:2669-2680
32. Perrien DS, Akel NS, Edwards PK, Carver AA, Bendre MS, Swain FL, Skinner RA, Hogue WR, Nicks KM, Pierson TM, Suva LJ, Gaddy D: Inhibin A is an endocrine stimulator of bone mass and strength. Endocrinology 2007, 148:1654-1665
33. Scott JP, Montgomery RR, Retzinger GS: Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets. J Biol Chem 1991, 266:8149-8155
34. Miller JL: Platelet-type von Willebrand disease. Thromb Haemost 1996, 75:865-869
35. Sporn LA, Marder VJ, Wagner DD: Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 1986, 46:185-190
36. Kacena MA, Gundberg CM, Horowitz MC: A reciprocal regulatory interaction between megakaryocytes, bone cells, and hematopoietic stem cells. Bone 2006, 39:978-984
37. Bowen DJ, Collins PW: Insights into von Willebrand factor proteolysis: clinical implications. Br J Haematol 2006, 133:457-467
38. Kacena MA, Shivdasani RA, Wilson K, Xi Y, Troiano N, Nazarian A, Gundberg CM, Bouxsein ML, Lorenzo JA, Horowitz MC: Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2. J Bone Miner Res 2004, 19:652-660
39. Yan XQ, Lacey D, Hill D, Chen Y, Fletcher F, Hawley RG, McNiece IK: A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation. Blood 1996, 88:402-409
40. Zieger B, Hashimoto Y, Ware J: Alternative expression of platelet glycoprotein Ibβ mRNA from an adjacent 5′ gene with an imperfect polyadenylation signal sequence. J Clin Invest 1997, 99:520-525
41. Ware J: Molecular analyses of the platelet glycoprotein Ib-IX-V receptor. Thromb Haemost 1998, 79:466-478
42. Cappellen D, Luong-Nguyen NH, Bongiovanni S, Grenet O, Wanke C, Susa M: Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa B. J Biol Chem 2002, 277:21971-21982
43. Ishida N, Hayashi K, Hoshijima M, Ogawa T, Koga S, Miyatake Y, Kumegawa M, Kimura T, Takeya T: Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem 2002, 277:41147-41156
44. Ware J, Dent JA, Azuma H, Sugimoto M, Kyrle PA, Yoshioka A, Ruggeri ZM: Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet GP Ib-IX receptor. Proc Natl Acad Sci USA 1991, 88:2946-2950
45. Nurden P, Debili N, Vainchenker W, Bobe R, Bredoux R, Corvazier E, Combrie R, Fressinaud E, Meyer D, Nurden AT, Enouf J: Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia. Blood 2006, 108:2587-2595
46. Hashimoto Y, Ware J: Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ibα gene. J Biol Chem 1995, 270:24532-24539
47. Vyas P, Ault K, Jackson CW, Orkin SH, Shivdasani RA: Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood 1999, 93:2867-2875
48. Shivdasani RA: The role of transcription factor NF-E2 in megakaryocyte maturation and platelet production. Stem Cells 1996, 14:112-115
49. Bord S, Frith E, Ireland DC, Scott MA, Craig JI, Compston JE: Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL. Bone 2005, 36:812-819
50. Rogers A, Eastell R: Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab 2005, 90:6323-6331
51. Sipe JB, Zhang J, Waits C, Skikne B, Garimella R, Anderson HC: Localization of bone morphogenetic proteins (BMPs)-2, -4, and -6 within megakaryocytes and platelets. Bone 2004, 35:1316-1322
52. Garimella R, Kacena MA, Tague SE, Wang J, Horowitz MC, Anderson HC: Expression of bone morphogenetic proteins and their receptors in the bone marrow megakaryocytes of GATA-1(low) mice: a possible role in osteosclerosis. J Histochem Cytochem 2007, 55:745-752
53. Kaneko H, Arakawa T, Mano H, Kaneda T, Ogasawara A, Nakagawa M, Toyama Y, Yabe Y, Kumegawa M, Hakeda Y: Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone 2000, 27:479-486
54. Wutzl A, Brozek W, Lernbass I, Rauner M, Hofbauer G, Schopper C, Watzinger F, Peterlik M, Pietschmann P: Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation. J Biomed Mater Res A 2006, 77:75-83
55. Okamoto M, Murai J, Yoshikawa H, Tsumaki N: Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. J Bone Miner Res 2006, 21:1022-1033
56. Huizinga EG, Tsuji S, Romijn RA, Schiphorst ME, de Groot PG, Sixma JJ, Gros P: Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain. Science 2002, 297:1176-1179